pankajmathur/National_Library_of_Medicine_Studies_data huggingface dataset:
Clinical trial: A Family-based, Resilience-focused Intervention for War-affected Communities in North-eastern Democratic Republic of Congo
Status: COMPLETED
Conditions: Psychological Distress
Interventions: BEHAVIORAL: Family-Focused, Community-Based, Resilience-Targetting Psychosocial Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Ticagrelor or Prasugrel Versus Clopidogrel in Elderly Patients With an Acute Coronary Syndrome and a High Bleeding Risk: Optimization of Antiplatelet Treatment in High-risk Elderly
Status: COMPLETED
Conditions: Non-ST-elevation Acute Coronary Syndrome|Unstable Angina|Non-ST-elevation Myocardial Infarction
Interventions: DRUG: Clopidogrel|DRUG: Ticagrelor or Prasugrel
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: VE416 for Treatment of Food Allergy
Status: RECRUITING
Conditions: Peanut Allergy
Interventions: COMBINATION_PRODUCT: Vancomycin plus VE416 before PNOIT|COMBINATION_PRODUCT: Vancomycin plus VE416 with PNOIT|COMBINATION_PRODUCT: Placebo plus VE416 with PNOIT|COMBINATION_PRODUCT: Placebo plus placebo with PNOIT
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: BioFINDER-Brown: Examination of Alzheimer's Disease Biomarkers
Status: RECRUITING
Conditions: Alzheimer Disease|Mild Cognitive Impairment|Dementia
Interventions: DIAGNOSTIC_TEST: Flutemetamol F18 Injection|DIAGNOSTIC_TEST: [18F]-RO6958948 Injection|DIAGNOSTIC_TEST: [18F]-MK-6240 Injection
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: MK-8228 (Letermovir) in the Prevention of Human Cytomegalovirus (CMV) Infection and Disease in Adult Japanese Kidney Transplant Recipients (MK-8228-042)
Status: COMPLETED
Conditions: Cytomegalovirus Infection|Cytomegalovirus Disease
Interventions: DRUG: Letermovir tablet|DRUG: Letermovir IV
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Translational Therapy in Patients With Osteogenesis Imperfecta - A Pilot Trial on Treatment With the Rankl-Antibody Denosumab
Status: COMPLETED
Conditions: Osteogenesis Imperfecta
Interventions: DRUG: Denosumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Allogenomic Mismatch Score (AMS) Applied to Haplo-identical Donor/Recipient Pairs in Haematopoietic Stem Cell Transplantation
Status: COMPLETED
Conditions: Stem Cell Transplantation|Haplo-identical
Interventions: OTHER: Assessment of the Allogenomic Mismatch Score (AMS)|OTHER: Assessment of the optimised Allogenomic Mismatch Score (AMS)
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: A Study of the Efficacy and Safety of Pregabalin for the Treatment of Fibromyalgia
Status: COMPLETED
Conditions: Fibromyalgia
Interventions: DRUG: Pregabalin|DRUG: Pregabalin|DRUG: Pregabalin|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase I/II, Open-label, Multi-center Study of [225Ac]Ac-PSMA-R2 in Men With PSMA-positive Prostate Cancer With or Without Prior 177Lu-PSMA Radioligand Therapy.
Status: RECRUITING
Conditions: Metastatic Castration-resistant Prostate Cancer (mCRPC)
Interventions: DRUG: 225Ac-PSMA-R2|RADIATION: 68Ga-PSMA-R2|RADIATION: 68Ga-PSMA-11
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Clear Aligners in Different Thicknesses
Status: COMPLETED
Conditions: Angle's Class I Malocclusion|Crowding, Tooth
Interventions: DEVICE: 0.5 mm-thick Duran® clear aligner|DEVICE: 0.75 mm-thick Duran® clear aligner
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Impact of MK-0518 (Raltegravir) Intensification on HIV-1 Viral Latency in Patients With Previous Complete Viral Suppression
Status: COMPLETED
Conditions: HIV Infections
Interventions: DRUG: MK-0518 400mg twice a day
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety Assessment of SAR341402 and NovoLog® Used in Continuous Subcutaneous Insulin Infusion for Type 1 Diabetes Mellitus Patients
Status: COMPLETED
Conditions: Type 1 Diabetes Mellitus
Interventions: DRUG: Insulin aspart SAR341402|DRUG: Insulin aspart
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Inhaled Corticosteroids After a Pediatric Emergency Visit for Asthma
Status: COMPLETED
Conditions: Asthma
Interventions: OTHER: ICS Prescription + Standard Asthma ED Discharge Therapy|OTHER: Standard Asthma ED Discharge Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Evaluation of Pneumococcal Vaccine Formulations in Young Adults
Status: COMPLETED
Conditions: Infections, Streptococcal
Interventions: BIOLOGICAL: Pneumococcal vaccine GSK2189242A|BIOLOGICAL: Pneumo 23™
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Effects of Plyometric Training on Endurance and Explosive Strength in Cricket Players
Status: COMPLETED
Conditions: Sports Physical Therapy
Interventions: OTHER: Plyometric training with warm up and cool down|OTHER: Conventional training with warm up & cool down
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: TAS-116 Plus Palbociclib in Breast and Rb-null Cancer
Status: RECRUITING
Conditions: Advanced Breast Cancer|Treatment-Refractory Solid Tumors|Retinoblastoma Deficiency|SCLC|Soft Tissue Sarcoma|Endometrial Cancer|Bladder Cancer
Interventions: DRUG: Palbociclib Oral Product|DRUG: TAS-116|DRUG: TAS-116|DRUG: TAS-116
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Determine the Efficacy&Safety of ARV-1801(ACG-701) for the Treatment of Cystic Fibrosis Pulmonary Exacerbations
Status: WITHDRAWN
Conditions: Cystic Fibrosis|Cystic Fibrosis Pulmonary Exacerbation
Interventions: DRUG: Sodium Fusidate|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: AURA 1: Augmenting Urinary Reflex Activity: Study 1
Status: WITHDRAWN
Conditions: Overactive Bladder|Urge Incontinence
Interventions: DEVICE: Picostim Amber
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Mobile App for Risk Reduction of Type 2 Diabetes
Status: RECRUITING
Conditions: Prediabetic State
Interventions: DEVICE: Mobile application|BEHAVIORAL: Group-based lifestyle intervention at a Healthy Lifestyle Centre + mobile application"|BEHAVIORAL: Group-based lifestyle intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Postural Control, Ankle and Trunk Proprioception in Type 2 Diabetes
Status: RECRUITING
Conditions: Type2diabetes
Interventions: OTHER: Semmes Weinstein Monofilament Test|OTHER: Proprioception measurement|OTHER: Postural control assessment|OTHER: Dynamic balance assessment|OTHER: Timed Up and Go Test|OTHER: Montreal Cognitive Assessment
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Evaluation of a Textile Scapula Orthosis
Status: COMPLETED
Conditions: Muscular Dystrophies|Scapular Dyskinesis|Muscular Dystrophy, Facioscapulohumeral|Muscle Weakness|Muscular Weakness|Muscular Dystrophy
Interventions: DEVICE: Scapula orthosis assistance|PROCEDURE: Manual scapula assistance|OTHER: No assistance|OTHER: Functional Test
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: ACT Guided Heparinization During Open Abdominal Aortic Aneurysm Repair.
Status: TERMINATED
Conditions: Abdominal Aortic Aneurysm|Surgery|Arterial Disease
Interventions: DRUG: ACT guided heparinization|DRUG: 5 000 IU of heparin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Study to Compare the Clinical and Radiological Efficacy of 625 mg Versus 1250 mg of Oral Methylprednisolone in Patients With Multiple Sclerosis in Relapse
Status: COMPLETED
Conditions: Multiple Sclerosis
Interventions: DRUG: Methylprednisolone 1250 mg/24h x3 days|DRUG: Oral Methylprednisolone 625 mg/24h x3 days
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Two Implementation Strategies for the Collection of Electronic Patient-Reported Outcomes Among Patients With Multiple Myeloma
Status: RECRUITING
Conditions: Multiple Myeloma
Interventions: OTHER: Planned Notification|OTHER: Survey Administration|BEHAVIORAL: Behavioral Intervention|OTHER: Electronic Health Record Review|OTHER: Interview|OTHER: Survey Administration|OTHER: Planned Notification|BEHAVIORAL: Behavioral Intervention|OTHER: Electronic Health Record Review|OTHER: Interview
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: HEALTH_SERVICES_RESEARCH
Clinical trial: The Effects of Acute Melatonin Supplementation on Cardiovascular Responses to Sympathetic Activation
Status: RECRUITING
Conditions: Healthy
Interventions: DIETARY_SUPPLEMENT: melatonin|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: BASIC_SCIENCE
Clinical trial: The Effects of Hydrogen-rich Formulation for Treatment of Sport-related Soft Tissue Injuries
Status: COMPLETED
Conditions: Soft Tissue Injuries
Interventions: DIETARY_SUPPLEMENT: HYDRO|DIETARY_SUPPLEMENT: ACTIVE|DIETARY_SUPPLEMENT: HYDRO 2
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Non-invasive Measurement of CO in Patients With Uncomplicated Sepsis
Status: COMPLETED
Conditions: Sepsis
Interventions: OTHER: Passive leg raise (PLR)|OTHER: Clearsight non-invasive hemodynamic monitoring system
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: TBE Seropersistence up to 10 Years After First Booster in Adults
Status: COMPLETED
Conditions: Tick-borne Encephalitis (TBE)
Interventions: BIOLOGICAL: FSME-IMMUN 0.5 ml
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Assessment of a Radiomics-based Computer-Aided Diagnosis Tool for Pulmonary nodulES
Status: RECRUITING
Conditions: Lung Cancer|Pulmonary Nodule, Solitary
Interventions: DEVICE: Optellum Virtual Nodule Clinic
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Study of the Clinical Effectiveness of a Human Monoclonal Antibody to C. Difficile Toxin A and Toxin B in Patients With Clostridium Difficile Associated Disease
Status: COMPLETED
Conditions: Clostridium Infections
Interventions: BIOLOGICAL: GS-CDA1/MDX-1388|BIOLOGICAL: normal saline
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: In-person and Online Healthy Eating Promotion Through Self-regulation (HEP-S)
Status: UNKNOWN
Conditions: Healthy Eating
Interventions: BEHAVIORAL: Online Program: Healthy Eating Promotion with Self-regulation|BEHAVIORAL: Enhanced Online Program: Healthy Eating Promotion with Self-regulation
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Audiological and Quality of Life Outcomes of Anatomy Based Fitting in Patients Implanted by Robot Assisted Cochlear Implant Surgery (RACIS)
Status: RECRUITING
Conditions: Cochlear Implants|Sensorineural Hearing Loss, Bilateral
Interventions: DEVICE: Post-operative ABF followed by fitting according to clinical standard|DEVICE: Fitting according to clinical standard followed by post-operative ABF
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Effects of a Ketoacid Supplementation in Patients With Stage III to IV Renal Failure
Status: COMPLETED
Conditions: Renal Failure
Interventions: DIETARY_SUPPLEMENT: Ketoacids|DIETARY_SUPPLEMENT: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Cisplatin and Fluorouracil Compared With Carboplatin and Paclitaxel in Treating Patients With Inoperable Locally Recurrent or Metastatic Anal Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Anal Basaloid Carcinoma|Anal Canal Cloacogenic Carcinoma|Anal Squamous Cell Carcinoma|Metastatic Anal Canal Carcinoma|Recurrent Anal Canal Carcinoma|Stage IIIB Anal Canal Cancer|Stage IV Anal Canal Cancer
Interventions: DRUG: Capecitabine|DRUG: Carboplatin|DRUG: Cisplatin|DRUG: Fluorouracil|OTHER: Laboratory Biomarker Analysis|DRUG: Paclitaxel|OTHER: Quality-of-Life Assessment
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Scintigraphy Study in Adults With Diabetic Gastroparesis
Status: TERMINATED
Conditions: Diabetic Gastroparesis
Interventions: DRUG: CIN-102 Dose 1|DRUG: CIN-102 Dose 2|DRUG: Placebo for CIN-102
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: The ESTxENDS Trial: Pulmonary Function Substudy
Status: COMPLETED
Conditions: Smoking Cessation|Pulmonary Disease
Interventions: OTHER: ENDS (vaporizer/e-cig) and smoking cessation counseling|OTHER: Smoking cessation counseling
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Neoadjuvant Atezolizumab in Surgically Resectable Advanced Cutaneous Squamous Cell Carcinoma
Status: ACTIVE_NOT_RECRUITING
Conditions: Cutaneous Squamous Cell Carcinoma
Interventions: DRUG: Atezolizumab
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Trial to Evaluate the Efficacy and Safety of CKD-386
Status: COMPLETED
Conditions: Dyslipidemia Patients With Hypertension
Interventions: DRUG: D013, D326, D337|DRUG: placebo of D013, D326, D337|DRUG: D013, placebo of D326, placebo of D337
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Study of the Efficacy and Safety of BP101 in Female Patients With Decrease or Loss of Sexual Desire
Status: COMPLETED
Conditions: Hypoactive Sexual Desire Disorder (HSDD)
Interventions: DRUG: BP101|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Computed Tomography With Stress Maneuvers for Evaluation of Distal Tibiofibular Syndesmosis Instability (CTMETS)
Status: RECRUITING
Conditions: Ankle Sprain
Interventions: DIAGNOSTIC_TEST: Comparative Ankle Tomography with Stress Maneuvers
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596 in Patients With Non-small Cell Lung Cancer, Breast Cancer, Head and Neck Cancer and Patients With Inflammations
Status: COMPLETED
Conditions: Diagnostic Imaging
Interventions: DRUG: BAY86-9596|DRUG: BAY86-9596|DRUG: BAY86-9596|DRUG: Fludeoxyglucose (18F)-IBA
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Effects of Cosopt on IOP and on Ocular Diastolic Perfusion Pressure
Status: UNKNOWN
Conditions: Glaucoma
Interventions: DRUG: Xalatan+Cosopt|DRUG: Xalatan
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Nilotinib With Chemotherapy for the Treatment of Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Status: TERMINATED
Conditions: Precursor B-Cell Lymphoblastic Leukemia-Lymphoma|Acute Lymphoblastic Leukemia
Interventions: DRUG: Nilotinib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Clinical Evaluation of Hair Removal and Permanent Hair Reduction for Skin Types VI Using Intense Pulsed Light
Status: TERMINATED
Conditions: Removal of Excess or Unwanted Body Hair
Interventions: DEVICE: Treatment group|OTHER: No intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Dual-task Training in Chronic Stroke
Status: UNKNOWN
Conditions: Stroke
Interventions: BEHAVIORAL: Dual-task training group|BEHAVIORAL: Single-task training group|BEHAVIORAL: Flexibility and strength training group
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Respiratory Muscle Training Combined With Aerobic Exercise in Obstructive Sleep Apnea Syndrome
Status: COMPLETED
Conditions: Obstructive Sleep Apnea Syndrome
Interventions: OTHER: Gradual Aerobic exercise training AND Respiratory muscle training|OTHER: Gradual Aerobic exercise training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: TREATMENT
Clinical trial: Development of Non-invasive Method for Quantifying Vitamin D Levels in the Body Using Spectroscopy
Status: UNKNOWN
Conditions: Deficiency of Vitamin D Blood Test
Interventions: DEVICE: No intervention,The group with vitamin D deficient will be treated by the Endocrinology Department by loading of vitamin D
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Lanreotide as Primary Treatment for Acromegalic Patients With Pituitary Gland Macroadenoma
Status: COMPLETED
Conditions: Acromegaly
Interventions: DRUG: Lanreotide autogel 120 mg
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effectiveness of Nutrition Education Intervention on Glycemic Control (HbA1c)
Status: COMPLETED
Conditions: Type 2 Diabetes|Diet, Healthy|Health Knowledge, Attitudes, Practice
Interventions: BEHAVIORAL: Nutrition Education Intervention
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: Efficacy of Citicoline Eye Drops 2% on Visual Field Preservation in Patients With Open Angle Glaucoma
Status: RECRUITING
Conditions: Glaucoma, Open-Angle
Interventions: DRUG: Citicoline eye drops 2%|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Treatment Effects of Family Based Cognitive Therapy in Children and Adolescents With Obsessive Compulsive Disorder
Status: ACTIVE_NOT_RECRUITING
Conditions: Obsessive-Compulsive Disorder in Children|Obsessive-Compulsive Disorder in Adolescence
Interventions: BEHAVIORAL: Family Based Cognitive Behavioural Therapy|BEHAVIORAL: Family Based Psychoeducation/Relaxation Training
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Mechanistic Evaluation of Guanfacine on Drinking Behavior in Women and Men With Alcohol Use Disorders
Status: RECRUITING
Conditions: Alcohol Use
Interventions: DRUG: Guanfacine ER|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase Ia/Ib Clinical Trial of IBI360 Monotherapy or in Combination With Sintilimab and (or) Chemotherapy in Advanced or Metastatic Solid Tumors
Status: UNKNOWN
Conditions: Advanced Solid Tumor
Interventions: DRUG: IBI 360 Injection
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate Safety and Efficacy of APO-2 at Three Different Doses in Patients With Diabetic Foot Ulcer
Status: COMPLETED
Conditions: Diabetic Foot Ulcer (DFU)
Interventions: BIOLOGICAL: APO-2|OTHER: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Guided Bone Regeneration Versus Bone Block Grafting
Status: COMPLETED
Conditions: Atrophy; Bone
Interventions: PROCEDURE: Khoury technique|PROCEDURE: Guided bone regeneration
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Status: COMPLETED
Conditions: Endometrial Adenocarcinoma|Endometrial Clear Cell Adenocarcinoma|Endometrial Mucinous Adenocarcinoma|Endometrial Serous Adenocarcinoma|Endometrial Squamous Cell Carcinoma|Endometrial Transitional Cell Carcinoma|Endometrial Undifferentiated Carcinoma|Endometrioid Adenocarcinoma|Recurrent Uterine Corpus Carcinoma|Stage III Uterine Corpus Cancer AJCC v7|Stage IIIA Uterine Corpus Cancer AJCC v7|Stage IIIB Uterine Corpus Cancer AJCC v7|Stage IIIC Uterine Corpus Cancer AJCC v7|Stage IV Uterine Corpus Cancer AJCC v7|Stage IVA Uterine Corpus Cancer AJCC v7|Stage IVB Uterine Corpus Cancer AJCC v7
Interventions: DRUG: Carboplatin|DRUG: Dasatinib|OTHER: Laboratory Biomarker Analysis|DRUG: Paclitaxel
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Single Rising Oral Doses of BI 1021958 in Healthy Chinese and Japanese Male Volunteers
Status: COMPLETED
Conditions: Healthy
Interventions: DRUG: matching placebo|DRUG: Test drug|DRUG: matching placebo|DRUG: Test drug|DRUG: Test drug|DRUG: Test drug|DRUG: Test drug|DRUG: matching placebo|DRUG: matching placebo|DRUG: matching placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE|Primary Purpose: TREATMENT
Clinical trial: The Effect of Gemfibrozil, Ketoconazole and Clarithromycin on the Amount of LY2409021 in the Bloodstream
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: LY2409021|DRUG: Gemfibrozil|DRUG: Ketoconazole|DRUG: Clarithromycin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Precision of 3 Dimensional Facial Analysis Using Bellus 3D Face Camera Pro Versus Planmeca ProMax 3D Proface: A Diagnostic Accuracy Study
Status: UNKNOWN
Conditions: 3 Dimensional Soft Tissue Facial Analysis
Interventions: DEVICE: "Bellus 3D Face Camera"|DEVICE: "Planmeca ProMax 3D Proface"
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: DIAGNOSTIC
Clinical trial: RCT of Postoperative Infections Following Caesarean Section Infections Following Caesarean Section
Status: WITHDRAWN
Conditions: Postoperative Infection
Interventions: DRUG: Cefuroxime
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Measurement of NK Cell Activity in Whole Blood in Subjects Being Screened for Colorectal Cancer Using Colonoscopy
Status: COMPLETED
Conditions: Natural Killer Cell Cytokine Production
Interventions: DEVICE: NK Vue: NK cell activity in stimulated whole blood
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: SCREENING
Clinical trial: UAB HRFD Core Center: Core A: The Hepato/Renal Fibrocystic Diseases Translational Resource
Status: RECRUITING
Conditions: Hepato/Renal Fibrocystic Disease|Autosomal Recessive Polycystic Kidney Disease|Joubert Syndrome|Bardet Biedl Syndrome|Meckel-Gruber Syndrome|Congenital Hepatic Fibrosis|Caroli Syndrome|Oro-Facial-Digital Syndrome Type I|Nephronophthisis|Glomerulocystic Kidney Disease
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Temozolomide and Bevacizumab in Treating Patients With Metastatic Melanoma of the Eye
Status: UNKNOWN
Conditions: Intraocular Melanoma
Interventions: BIOLOGICAL: bevacizumab|DRUG: temozolomide|GENETIC: polymorphism analysis|OTHER: pharmacogenomic studies
Study Type: INTERVENTIONAL
Study Design: Allocation: |Intervention Model: |Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Functional Magnetic Resonance Imaging Study of the Central Auditory System After Single Sided Deafness
Status: COMPLETED
Conditions: Unilateral Hearing Loss
Interventions: OTHER: functional magnetic resonance imaging
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: General vs. Intrathecal Anesthesia for Total Knee Arthroplasty
Status: COMPLETED
Conditions: Arthritis
Interventions: PROCEDURE: General anesthesia|PROCEDURE: Regional anesthesia
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Phase 1 Dose Escalation Study of CGX1321 in Subjects With Advanced Gastrointestinal Tumors
Status: UNKNOWN
Conditions: Colorectal Adenocarcinoma|Gastric Adenocarcinoma|Pancreatic Adenocarcinoma|Bile Duct Carcinoma|Hepatocellular Carcinoma|Esophageal Carcinoma|Gastrointestinal Cancer
Interventions: DRUG: CGX1321
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Safety and Efficacy of Autologous NK Cell Adjuvant Therapy for Relapsed/Refractory Non-Hodgkin's B-cell Lymphoma
Status: NOT_YET_RECRUITING
Conditions: NK Cell|B-cell Lymphoma Recurrent|B-cell Lymphoma Refractory
Interventions: COMBINATION_PRODUCT: autologous NK cell
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Prospective Clinical Trial of Three Apical Sealing Materials
Status: COMPLETED
Conditions: Periapical Abscess
Interventions: DRUG: EndoSequence|DRUG: ProRoot MTA|DRUG: Biodentine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Erythropoietin (EPO) and Ischemia-reperfusion After Kidney Transplantation
Status: COMPLETED
Conditions: Kidney Transplantation
Interventions: DRUG: Recombinant erythropoietin alpha (rHuEPO alpha)|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: PREVENTION
Clinical trial: Post-Operative Pain After Uniportal Vats Lobectomy: Does A Smaller Incision Result In Better Recovery?
Status: COMPLETED
Conditions: Pain
Interventions: PROCEDURE: Lobectomy via UVATS
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Can The Bridge Transition Opiate Use Disorder Patients in Stable Recovery From Buprenorphine to Naltrexone
Status: WITHDRAWN
Conditions: Substance Use Disorders|Substance Abuse|Substance Use|Substance Dependence
Interventions: DEVICE: The Bridge
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Determination of the PPG and Insulin Responses of Rice Alone and Rice Consumed With Sugardown™
Status: COMPLETED
Conditions: Postprandial Hyperglycemia
Interventions: DIETARY_SUPPLEMENT: Rice|DIETARY_SUPPLEMENT: Sugardown™
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A 10 Week Open-Label Pilot Study to Evaluate the Effectiveness and Safety of Memantine(Namenda) as Augmentation Therapy in Patients With Generalized Anxiety Disorder
Status: COMPLETED
Conditions: General Anxiety Disorder, Social Anxiety Disorder
Interventions: DRUG: Namenda/Memantine
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: BTT1023 in Psoriasis
Status: COMPLETED
Conditions: Plaque Psoriasis
Interventions: DRUG: BTT1023|DRUG: Placebo|DRUG: BTT1023
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Spectral Dynamic Imaging of Cognitive Functions in Epileptic Patients Explored Stereoelectroencephalography
Status: COMPLETED
Conditions: Epilepsy
Interventions: PROCEDURE: Spectral Dynamic Imaging|DEVICE: Hybride electrode|DEVICE: Macro electrode
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Efficacy and Safety of GSK3923868 Inhalation Powder, During Experimental Human Rhinovirus Infection in Participants With Mild Asthma
Status: COMPLETED
Conditions: Pulmonary Disease, Chronic Obstructive
Interventions: DRUG: GSK3923868|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Narlumosbart Compared With Denosumab in Patients With Multiple Myeloma Bone Disease
Status: NOT_YET_RECRUITING
Conditions: Multiple Myeloma|Bone Diseases
Interventions: DRUG: Narlumosbart|DRUG: Denosumab
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: SUPPORTIVE_CARE
Clinical trial: A Pharmacokinetic Study of SID1903 (FDC of Dapagliflozin and Sitagliptin) in Healthy Adult Volunteers
Status: COMPLETED
Conditions: Healthy Subjects
Interventions: DRUG: SID1903 (FDC)|DRUG: Dapagliflozin and Sitagliptin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Absorption of Indacaterol and Glycopyrronium From Ultibro Breezhaler
Status: COMPLETED
Conditions: Healthy Volunteers
Interventions: DRUG: Indacaterol maleate and glycopyrronium bromide|DRUG: Indacaterol maleate and glycopyrronium bromide|DRUG: Indacaterol maleate and glycopyrronium bromide|DRUG: Ultibro Breezhaler with oral charcoal
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: NONE|Primary Purpose: BASIC_SCIENCE
Clinical trial: Radiation Therapy and Docetaxel in Treating Patients Who Are Undergoing Surgery for Localized Prostate Cancer
Status: TERMINATED
Conditions: Prostate Cancer
Interventions: RADIATION: Intensity-Modulated Radiation Therapy (IMRT)|DRUG: Docetaxel+IMRT
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Brentuximab Vedotin Followed by ABVD in Patients With Previously Untreated Hodgkin Lymphoma
Status: UNKNOWN
Conditions: Hodgkin Lymphoma
Interventions: DRUG: Brentuximab vedotin|DRUG: ABVD
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Single Doses of Mipomersen in Japanese Healthy Volunteers
Status: COMPLETED
Conditions: Healthy Volunteer
Interventions: DRUG: mipomersen|DRUG: placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Carbetocin vs. Oxytocin at Elective Cesarean Section
Status: COMPLETED
Conditions: Postpartum Hemorrhage
Interventions: DRUG: Carbetocin|DRUG: Oxytocin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Thymoglobulin and Cyclosporine in Patients With Aplastic Anemia or Myelodysplastic Syndrome
Status: COMPLETED
Conditions: Myelodysplastic Syndrome|Aplastic Anemia
Interventions: DRUG: Thymoglobulin|DRUG: Cyclosporine|DRUG: Methylprednisolone|DRUG: G-CSF
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Phase 1/2 Study of Enasidenib (AG-221) in Adults With Advanced Hematologic Malignancies With an Isocitrate Dehydrogenase Isoform 2 (IDH2) Mutation
Status: COMPLETED
Conditions: Hematologic Neoplasms
Interventions: DRUG: Enasidenib
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SEQUENTIAL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: COMT Inhibition Among Individuals With Comorbid AUD/ADHD
Status: RECRUITING
Conditions: Alcohol Use Disorder|Attention Deficit Hyperactivity Disorder
Interventions: DRUG: Tolcapone|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: CROSSOVER|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: BASIC_SCIENCE
Clinical trial: SOUND Pivotal Trial - (Sonomotion stOne comminUtion resoNance ultrasounD)
Status: RECRUITING
Conditions: Kidney Stone|Urolithiasis|Nephrolithiasis|Renal Calculi|Kidney Calculi|Nephrolith|Urinary Calculi
Interventions: DEVICE: Break Wave extracorporeal lithotripsy
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy and Safety of Atezolizumab Plus Capecitabine Adjuvant Therapy for Triple Receptor-Negative Breast Cancer
Status: ACTIVE_NOT_RECRUITING
Conditions: Triple Negative Breast Cancer
Interventions: DRUG: Atezolizumab|DRUG: Capecitabine
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Pazopanib in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Status: UNKNOWN
Conditions: Head and Neck Squamous Cell Carcinoma
Interventions: DRUG: Pazopanib
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: The Use of Functional Electrical Stimulation in Conjunction With Respiratory Muscle Training to Improve Unaided Cough in Individuals With Acute Spinal Cord Injury
Status: RECRUITING
Conditions: Acute Spinal Cord Injury
Interventions: DEVICE: Xcite Clinical Station
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults
Status: COMPLETED
Conditions: Tuberculosis|Tuberculosis Vaccines
Interventions: BIOLOGICAL: GSK Biologicals' investigational TB vaccine (GSK692342)|BIOLOGICAL: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Effect Web Based Pregnancy Preparation Education According to Health Promotion Model in Preconceptional Period on Women
Status: NOT_YET_RECRUITING
Conditions: Health Promotion
Interventions: DIAGNOSTIC_TEST: Web Based Pregnancy Preparation Education Structured According to the Health Promotion Model Knowledge Attitude and Health Behaviors
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Prospective Evaluation of the Connected EMY Biofeedback Probe in the Management of Stress Urinary Incontinence.
Status: COMPLETED
Conditions: Stress Urinary Incontinence
Interventions: DEVICE: intravaginal device (probe) EMY
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Beta Cell Function Tests Over Time In Patients With T2dm Randomized To Metformin Or Rosiglitazone
Status: TERMINATED
Conditions: Type 2 Diabetes Mellitus
Interventions: DRUG: Rosiglitazone|DRUG: Metformin
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: DIAGNOSTIC
Clinical trial: Use of Disposable Cuff Cover to Prevent Carriage of Pathogen Microorganisms Originated by Cuffs
Status: UNKNOWN
Conditions: Pathogen Transmission, Vertical|Nosocomial Infection|Cross Infection|Cuff
Interventions: OTHER: Presence or Absence of a Blood Pressure Cuff Sheath
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: PREVENTION
Clinical trial: Fecal Microbiota Transplantation for C. Difficile Infection in Solid Organ Transplant Recipients
Status: COMPLETED
Conditions: Clostridium Difficile Infection Recurrence
Interventions: DRUG: FMT oral capsule|DRUG: Oral Vancomycin|DRUG: FMT oral placebo|DRUG: Oral Vancomycin placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase 1 Study of the Safety, Tolerability and Pharmacokinetics of ABT-126 in Subjects With Alzheimer's Disease
Status: COMPLETED
Conditions: Alzheimer's Disease
Interventions: DRUG: ABT-126|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose:
Clinical trial: Perioperative Personalized Blood Pressure Management
Status: COMPLETED
Conditions: Blood Pressure|Intraoperative Hypotension|Postoperative Complications
Interventions: OTHER: Personalized management
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Prevention for Positives: An RCT Among Vietnamese HIV-positive IDU
Status: COMPLETED
Conditions: HIV
Interventions: BEHAVIORAL: Individual level|BEHAVIORAL: Structural level|BEHAVIORAL: Individual level standard of care|BEHAVIORAL: Structural level standard of care
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: FACTORIAL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
Clinical trial: Retrospective Evaluation of the Effect of Ultrasound-guided Obturator Nerve Block on Complications in Transurethral (TUR-M) Resection Surgery for Bladder Side Wall Tumors.
Status: COMPLETED
Conditions: Efficacy of Peripheral Nerve Blocks on Complications, Morbidity and Mortality
Study Type: OBSERVATIONAL
Study Design: Observational Model: |Time Perspective: p
Clinical trial: Study of Cytoreductive Surgery and Hyperthermic Intraoperative Chemotherapy With Pemetrexed and Cisplatin for MPM
Status: TERMINATED
Conditions: Mesothelioma
Interventions: DRUG: Pemetrexed|DRUG: Cisplatin
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: OTHER
Clinical trial: HDM201 Added to CT in R/R or Newly Diagnosed AML
Status: WITHDRAWN
Conditions: Leukemia, Myeloid, Acute
Interventions: DRUG: HDM201|DRUG: cytarabine|DRUG: anthracycline|DRUG: midostaurin|DRUG: liposomal cytarabine/daunorubicin|DRUG: posaconazole|DRUG: midazolam
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Efficacy of Doxycycline in the Treatment of Early Stages of Mycosis Fungoides
Status: UNKNOWN
Conditions: Lymphoma
Interventions: DRUG: Vibramycin|DEVICE: Phototherapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Treatment of Peri-Implant Mucositis With Standard of Care and Bioptron Hyperlight Therapy
Status: COMPLETED
Conditions: Mucositis Oral|Dental Implant Failed
Interventions: DEVICE: Photobiomodulation with Bioptron Hyperlight Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase II Study of Paclitaxel and Topotecan With Filgrastim-SD/01 Support For Relapsed and Refractory Aggressive Non-Hodgkin's Lymphoma
Status: COMPLETED
Conditions: Non-Hodgkin's Lymphoma
Interventions: DRUG: Filgrastim SD/01|DRUG: Paclitaxel|DRUG: Topotecan
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Study to Evaluate Pharmacokinetics of ITCA 650 in Subjects With Renal Impairment Compared to Normal Subjects
Status: COMPLETED
Conditions: Renal Insufficiency
Interventions: DRUG: ITCA 650 (Exenatide in osmotic mini pump)
Study Type: INTERVENTIONAL
Study Design: Allocation: NON_RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery
Status: ACTIVE_NOT_RECRUITING
Conditions: Opioid Use, Unspecified|Bariatric Surgery Candidate|Anesthesia
Interventions: DRUG: Opioid Anesthetics|DRUG: Non Opioid Analgesics
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (PARTICIPANT)|Primary Purpose: OTHER
Clinical trial: Anchorage Reinforcement in Bimaxillary Proclination Cases
Status: ACTIVE_NOT_RECRUITING
Conditions: Bimaxillary Proclination
Interventions: DEVICE: transpalatal arch group|DEVICE: Nance button
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: Effects of Rhythmic Auditory Cueing Augments Cognitive Treadmill Walking Training in Individuals With Chronic Stroke
Status: NOT_YET_RECRUITING
Conditions: Stroke
Interventions: DEVICE: Cognitive Treadmill Walking Training with Rhythmic Auditory Cueing (CTW+RAC) group|DEVICE: Cognitive Treadmill Walking Training (CTW) group|DEVICE: Treadmill Walking Training (TW)
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: SINGLE (OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: High Flow Nasal Cannula in Patients Undergoing Colonoscopy
Status: NOT_YET_RECRUITING
Conditions: Colonoscopy
Interventions: DEVICE: High Flow Nasal Cannula|DEVICE: Conventional Oxygen Therapy
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: DOUBLE (PARTICIPANT, INVESTIGATOR)|Primary Purpose: TREATMENT
Clinical trial: Pilot Study of Allogeneic Tumor Cell Vaccine With Metronomic Oral Cyclophosphamide and Celecoxib in Patients Undergoing Resection of Lung and Esophageal Cancers, Thymic Neoplasms, and Malignant Pleural Mesotheliomas
Status: TERMINATED
Conditions: Lung Cancer|Esophageal Cancer|Malignant Pleural Mesothelioma|Sarcoma|Thymic Carcinoma
Interventions: BIOLOGICAL: Allogeneic Tumor Cell Vaccine (K562)|DRUG: Celecoxib|DRUG: cyclophosphamide
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Veritas Laparoscopic Paraesophageal Hiatal Hernia (PEH) Repair Pilot Trial
Status: COMPLETED
Conditions: Hiatal Hernia
Interventions: DEVICE: Veritas® Collagen Matrix
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: D-chiro-inositol and AUB
Status: NOT_YET_RECRUITING
Conditions: Abnormal Uterine Bleeding
Interventions: DIETARY_SUPPLEMENT: D-chiro-inositol and lactalbumin (high dose)|DIETARY_SUPPLEMENT: D-chiro-inositol and lactalbumin (low dose)
Study Type: INTERVENTIONAL
Study Design: Allocation: NA|Intervention Model: SINGLE_GROUP|Masking: NONE|Primary Purpose: TREATMENT
Clinical trial: Evaluation of the Efficacy and Safety of VX-814 in Subjects With the PiZZ Genotype
Status: TERMINATED
Conditions: Alpha 1-Antitrypsin Deficiency
Interventions: DRUG: VX-814|DRUG: Placebo
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: TREATMENT
Clinical trial: A Phase 1, Randomised, Double-blinded, Placebo-controlled, Dose-escalation Study to Evaluate the Safety and Immunogenicity of RH109 as Booster
Status: WITHDRAWN
Conditions: COVID-19 Pandemic
Interventions: BIOLOGICAL: Lyophilized COVID-19 mRNA Vaccine|DRUG: Sodium chloride
Study Type: INTERVENTIONAL
Study Design: Allocation: RANDOMIZED|Intervention Model: SEQUENTIAL|Masking: QUADRUPLE (PARTICIPANT, CARE_PROVIDER, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION